Showing results (1321-1330 of 2,457) with videos related to
Sort By:
Pageof 246
The Journal of Investigative Dermatology|September 1, 1986
A mouse model for vitiligoA B Lerner, T Shiohara, R E Boissy, et al.Acta Crystallographica. Section C, Crystal Structure Communications|November 15, 2000
Disappearance of intramolecular stacking due to one-atom movement or increment of a 'propylene linker' in pyrazolo[3,4-d]pyrimidine-based flexible modelsP R Maulik, K Avasthi, S Sarkhel, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeineR A Mathôt, J M Gubbens-Stibbe, W Soudijn, et al.Science (New York, N.Y.)|August 18, 2004
Discovery of mass anomalies on GanymedeJohn D Anderson, Gerald Schubert, Robert A Jacobson, et al.Journal of Medicinal Chemistry|April 1, 1983
Conjugates of catecholamines. 1. N-alkyl-functionalized carboxylic acid congeners and amides related to isoproterenolK A Jacobson, D Marr-Leisy, R P Rosenkranz, et al.AJR. American Journal of Roentgenology|May 9, 1998
Detection of ankle effusions: comparison study in cadavers using radiography, sonography, and MR imagingJ A Jacobson, R Andresen, S Jaovisidha, et al.The American Journal of Medicine|January 4, 2014
Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemiaJennifer B Christian, Bhakti Arondekar, Erin K Buysman, et al.Atherosclerosis|June 24, 2014
Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targetsPeter P Toth, Michael Grabner, Rajeshwari S Punekar, et al.Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonistsBidhan A Shinkre, T Santhosh Kumar, Zhan-Guo Gao, et al.Cardiovascular Drugs and Therapy|June 1, 2016
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed HyperlipidemiaRobert S Rosenson, Terry A Jacobson, David Preiss, et al.Pageof 246